Literature DB >> 7126426

Practical experience of randomization in cancer trials: an international survey.

S J Pocock, S W Lagakos.   

Abstract

The results from an international survey of 15 major cancer centres have clarified how randomization is being implemented in cancer trials. As regards the mechanics of obtaining treatment assignment for each patient a system of telephone registration to a central randomization office was widely used. We also advise formal checks for patient eligibility immediately before treatment assignment, and subsequent written confirmation of randomization to the investigators. As regards statistical methods, stratification of randomization by one or two prognostic factors (and institution in multicentre trials) is commonplace. Most centres used the standard approach of random permuted blocks within strata though some others used "dynamic" institution-balancing or "minimization" methods instead. The value of stratified allocation is chiefly for the trial's credibility in having comparable treatment groups, rather than for statistical efficiency. One should avoid overstratification and use only the really important prognostic factors. One essential is that randomization should in practice work for every patient, so undue complexity is to be avoided.

Entities:  

Mesh:

Year:  1982        PMID: 7126426      PMCID: PMC2011110          DOI: 10.1038/bjc.1982.212

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  5 in total

1.  The randomization and stratification of patients to clinical trials.

Authors:  M Zelen
Journal:  J Chronic Dis       Date:  1974-09

2.  Allocation of patients to treatment in clinical trials.

Authors:  S J Pocock
Journal:  Biometrics       Date:  1979-03       Impact factor: 2.571

3.  A new design for randomized clinical trials.

Authors:  M Zelen
Journal:  N Engl J Med       Date:  1979-05-31       Impact factor: 91.245

4.  Allocation of patients to treatment groups in a controlled clinical study.

Authors:  S J White; L S Freedman
Journal:  Br J Cancer       Date:  1978-05       Impact factor: 7.640

5.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design.

Authors:  R Peto; M C Pike; P Armitage; N E Breslow; D R Cox; S V Howard; N Mantel; K McPherson; J Peto; P G Smith
Journal:  Br J Cancer       Date:  1976-12       Impact factor: 7.640

  5 in total
  4 in total

1.  Meta-analyses in cancer clinical trials: principles and pitfalls.

Authors:  J R Benson; K Saeb-Parsy
Journal:  World J Surg       Date:  2006-07       Impact factor: 3.352

2.  Conservative treatment of early breast cancer. Long-term results of 1232 cases treated with quadrantectomy, axillary dissection, and radiotherapy.

Authors:  U Veronesi; B Salvadori; A Luini; A Banfi; R Zucali; M Del Vecchio; R Saccozzi; E Beretta; P Boracchi; G Farante
Journal:  Ann Surg       Date:  1990-03       Impact factor: 12.969

3.  Current issues in the design and interpretation of clinical trials.

Authors:  S J Pocock
Journal:  Br Med J (Clin Res Ed)       Date:  1985-01-05

4.  An automated patient registration and treatment randomization system.

Authors:  C Papaconstantinou; J P Krischer
Journal:  J Med Syst       Date:  1995-12       Impact factor: 4.460

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.